Lord, Abbett & Co. LLC Olink Holding Ab (Publ) Transaction History

Lord, Abbett & Co. LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 07, 2024	BUY	$17.13 - $23.74 $283,227 - $392,517	16,534 Added 1.64%	1,027,751 $19.3 Million
Q2 2023 Aug 14, 2023	BUY	$17.13 - $23.74 $283,227 - $392,517	16,534 Added 1.64%	1,027,751 $19.3 Million
Q1 2023 Oct 07, 2024	BUY	$19.34 - $24.11 $12.3 Million - $15.4 Million	637,734 Added 170.75%	1,011,217 $22.8 Million
Q1 2023 May 12, 2023	BUY	$19.34 - $24.11 $12.3 Million - $15.4 Million	637,734 Added 170.75%	1,011,217 $22.8 Million
Q4 2022 Oct 07, 2024	BUY	$12.64 - $25.52 $4.72 Million - $9.53 Million	373,483 New	373,483 $9.48 Million
Q4 2022 Feb 10, 2023	BUY	$12.64 - $25.52 $4.72 Million - $9.53 Million	373,483 New	373,483 $9.48 Million
Q3 2021 Nov 09, 2021	SELL	$23.42 - $37.93 $9.26 Million - $15 Million	-395,584 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$26.65 - $39.47 $912,682 - $1.35 Million	-34,247 Reduced 7.97%	395,584 $13.6 Million
Q1 2021 May 11, 2021	BUY	$31.9 - $36.0 $13.7 Million - $15.5 Million	429,831 New	429,831 $15.5 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.